Hjem › Hjertesvigt › Minnesota › Minneapolis
Hjertesvigt kliniske forsøg i Minneapolis, MN
21 studier for Hjertesvigt søger deltagere på steder i og omkring Minneapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RekruttererFase 3
- Minneapolis VA Health Care System, Minneapolis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RekruttererFase 3
- Minneapolis VA Health Care System, Minneapolis
Alleviant ALLAY-HFrEF Study
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- University of Minnesota, Minneapolis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RekruttererFase 3
- Research Site, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekruttererFase 3
- Minneapolis, MN Investigative Site CON-10035, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Minneapolis, MN Investigative Site 10091, Minneapolis
- Minneapolis, MN Investigative Site 10035, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RekruttererObservationsstudie
- Minneapolis, Minneapolis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RekruttererObservationsstudie
- Minneapolis Heart Institute Foundation, Minneapolis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Minneapolis
Alleviant ALLAY-HF Study
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Rekrutterer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Assessment of CCM in HF With Higher Ejection Fraction
Rekrutterer
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RekruttererFase 3
- Minneapolis, MN Investigative Site FIN-10035, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- Minneapolis Heart Institute, Minneapolis
CCM OPEN HF Registry
RekruttererObservationsstudie
- Minneapolis Heart Institute Research Foundation, Minneapolis
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
RekruttererObservationsstudie
- Minneapolis Heart Institute Foundation, Minneapolis
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
RekruttererObservationsstudie
- Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Hjertesvigt forsøg i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- St. Louis, MO26 studier
- Durham, NC26 studier
- Kansas City, MO25 studier
- Atlanta, GA25 studier
Andre studier i Minneapolis
- Brystkræft27 studier
- Ikke-småcellet lungecancer26 studier
- Ægstockræft24 studier
- Prostatakræft23 studier
- Kræft (alle typer)22 studier
- Lungecancer20 studier
- Akut myeloid leukæmi20 studier
- Colorektal kræft19 studier
- Livmoderslimhindekræft18 studier
- Parkinsons sygdom17 studier
- Kardiovaskulær sygdom15 studier
- Koronar hjertesygdom13 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.